TORONTO & CAMBRIDGE, Mass.-(BUSINESS WIRE)-Deep Genomics, the leading AI therapeutics company, welcomes Tal Zaks, MD, PhD, to its Strategic Advisory... Read MoreThe post Tal Zaks Joins Strategic Advisory Board at Deep Genomics appeared first on citybiz.
Deep Genomics is a Canada-based biopharmaceutical company that researches and develops AI-driven RNA therapeutics for the treatment of genetic conditions.